- Home
- AMWD vs CMPX Comparison
AMWD vs CMPX Comparison
Compare AMWD & CMPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AMWD | CMPX |
|---|---|---|
| Founded | 1980 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Forest Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 803.2M | 752.4M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | AMWD | CMPX |
|---|---|---|
| Price | $55.36 | $5.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $64.50 | $13.44 |
| AVG Volume (30 Days) | 244.9K | ★ 2.2M |
| Earning Date | 11-25-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.25 | N/A |
| Revenue | ★ $1,595,658,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.63 | N/A |
| P/E Ratio | $13.22 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $47.15 | $1.33 |
| 52 Week High | $92.44 | $5.86 |
Technical Indicators
Market Signals| Indicator | AMWD | CMPX |
|---|---|---|
| Relative Strength Index (RSI) | 49.59 | 68.03 |
| Support Level | $53.01 | $5.13 |
| Resistance Level | $57.67 | $5.86 |
| Average True Range (ATR) | 2.26 | 0.33 |
| MACD | 1.06 | 0.03 |
| Stochastic Oscillator | 82.83 | 77.82 |
Price Performance
Historical ComparisonAbout AMWD American Woodmark Corporation
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.